Top

High Blood Pressure & Cardiovascular Prevention

Published in:

01-06-2019 | Obesity | Original Article

Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths

Authors: Ehsan Mazloumi, Jalal Poorolajal, Nizal Sarrafzadegan, Hamid Reza Roohafza, Javad Faradmal, Manoochehr Karami

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 3/2019

Abstract

Introduction

Contribution of risk factors for cardiovascular-related deaths in the Eastern Mediterranean Region Organization (EMRO) is not estimated quantitatively.

Aim

To determine the avoidable burden of cardiovascular diseases (CVDs) due to hypertension, diabetes, smoking, overweight, and obesity in countries of EMRO of the WHO.

Methods

The comparative risk assessment methodology was used to calculate the potential impact fraction (PIF) and percentage of the avoidable burden of CVD-related death due to associated risk factors. Population exposure levels for CVDs and corresponding measures of association were extracted from published studies. The attributable burden was calculated by multiplying the Disability-Adjusted Life-Years (DALYs) for CVDs by the estimated impact fraction of risk factors. DALYs of the CVDs in all countries of the EMRO were extracted from the GBD official website in 2016.

Results

Following reduction of the current prevalence of smoking, obesity, hypertension, diabetes, and overweight to a feasible minimum risk exposure level in Lebanon, about 12.4%, 4.2%, 10.2%, 3.8%, and 5.7% of the burden of CVD-related mortality could be avoidable, respectively. The corresponding values of avoidable burden in selected EMRO countries were 5.1%, 3.5%, 9.4%, 5.9% and 5.3% in Iran and 9.5%, 4.1%, 11%, 8.2% and 5.4% in Egypt.

Conclusions

Findings suggest that health policy makers of all EMRO countries should take into account the attributable burden of CVD-related mortality due to associated risk factors to effectively develop preventive interventions.

Available only for authorised users

Xu S, Jiayong Z, Li B, Zhu H, Chang H, Shi W, et al. Prevalence and clustering of cardiovascular disease risk factors among Tibetan adults in China: a population-based study. PloS One. 2015;10(6):e0129966. https://doi.org/10.1371/journal.pone.0129966.CrossRefPubMedPubMedCentral

World Health Organization. Cardiovascular diseases (CVDs) fact sheet. WHO. 2017. http://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 14 Aug 2017.

World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. WHO. 2007. http://www.who.int/cardiovascular_diseases/publications/Prevention_of_Cardiovascular_Disease/en/. Accessed 17 May 2018.

Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45. https://doi.org/10.1093/eurheartj/ehw334.CrossRefPubMed

Tehrani-Banihashemi A, Moradi-Lakeh M, El Bcheraoui C, Charara R, Khalil I, Afshin A. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2018;63(Suppl 1):137–49. https://doi.org/10.1007/s00038-017-1012-3.CrossRef

World Health Organization. Cardiovascular diseases. WHO. 2018. http://www.emro.who.int/health-topics/cardiovascular-diseases/index.html. Accessed 14 Aug 2017.

World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. WHO. 2009. http://www.who.int/iris/handle/10665/44203. Accessed 17 May 2018.

Dieleman JL, Baral R, Birger M, et al. Us spending on personal health care and public health, 1996–2013. JAMA. 2016;316(24):2627–46. https://doi.org/10.1001/jama.2016.16885.CrossRefPubMedPubMedCentral

Drescher K, Becher H. Estimating the generalized impact fraction from case-control data. Biometrics. 1997;53(3):1170–6. https://doi.org/10.2307/2533576.CrossRefPubMed

10.

Murray CJ, Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S. Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metrics. 2003;1(1):1.CrossRef

11.

World Health Organization. WHO global report on trends in prevalence of tobacco smoking. WHO. 2015. http://www.who.int/iris/handle/10665/156262. Accessed 17 May 2018.

12.

World Health Organization. Prevalence of obesity among adults, BMI ≥ 30, crude Estimates by country. WHO. 2017. http://apps.who.int/gho/data/node.main.BMI30C?lang=en. Accessed 17 May 2018.

13.

World Health Organization. Raised blood pressure (SBP ≥ 140 OR DBP ≥ 90), crude (%) Estimates by country. WHO Web Site. 2017. http://apps.who.int/gho/data/node.main.A875?lang=en. Accessed 17 May 2018.

14.

World Health Organization. Raised fasting blood glucose (≥ 7.0 mmol/L or on medication) (crude estimate) Estimates by country. WHO. 2017. http://apps.who.int/gho/data/node.main.A869?lang=en. Accessed 17 May 2018.

15.

Borrell LN, Samuel L. Body mass index categories and mortality risk in US adults: the effect of overweight and obesity on advancing death. Am J Public Health. 2014;104(3):512–9. https://doi.org/10.2105/ajph.2013.301597.CrossRefPubMedPubMedCentral

16.

Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, et al. Correction: PARS risk charts: a 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region. PLoS One. 2018;13(1):e0191379. https://doi.org/10.1371/journal.pone.0191379.CrossRefPubMedPubMedCentral

17.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet (Lond Engl). 2004;364(9438):937–52. https://doi.org/10.1016/s0140-6736(04)17018-9.CrossRef

18.

Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Km A. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1345–422. https://doi.org/10.1016/s0140-6736(17)32366-8.CrossRef

19.

GBD. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016. GBD. 2017. http://ghdx.healthdata.org/record/global-burden-disease-study-2016-gbd-2016-population-estimates-1950-2016. Accessed 17 May 2018.

20.

Cui F, Zhang L, Yu C, Hu S, Zhang Y. Estimation of the Disease Burden Attributable to 11 Risk Factors in Hubei Province, China: a comparative risk assessment. Int J Environ Res Public Health. 2016;13(10):944.CrossRefPubMedCentral

21.

Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4):e1000058. https://doi.org/10.1371/journal.pmed.1000058.CrossRefPubMedPubMedCentral

22.

World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. World Health Organization; 2002.

23.

Karami M, Khosravi Shadmani F, Najafi F. Estimating the contribution of diabetes on the attributable burden of cardiovascular diseases in Kermanshah, West of Iran. Iran J Epidemiol. 2012;8(3):33–8.

24.

Banegas JR, Rodríguez-Artalejo F, Graciani A, Villar F, Herruzo R. Mortality attributable to cardiovascular risk factors in Spain. Eur J Clin Nutr. 2003;57:S18. https://doi.org/10.1038/sj.ejcn.1601804.CrossRefPubMed

25.

Collaboration APCS. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific Regions. Asia Pacific J Clin Nutr. 2007;16(1):187–92. https://doi.org/10.6133/apjcn.2007.16.1.24.CrossRef

26.

Danaei G, Lawes CMM, Vander Hoorn S, Murray CJL, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368(9548):1651–9. https://doi.org/10.1016/S0140-6736(06)69700-6.CrossRefPubMed

27.

Azimi SS, Khalili D, Hadaegh F, Yavari P, Mehrabi Y, Azizi F. Calculating population attributable fraction for cardiovascular risk factors using different methods in a population based cohort study. J Res Health Sci. 2015;15(1):22–7.PubMed

28.

Eshrati B, Hasanzadeh J, Mohammad Beigi A. Calculation of population atributable burden of excess weight and obesity to non-contagious diseases in Markazi provience of Iran. Koomesh J. 2010;11(2):83–90.

29.

Biderafsh A, Karami M, Faradmal J, Poorolajal J. Estimating the potential impact fraction of hypertension as the main risk factor of stroke: Application of the distribution shift method. J Epidemiol Glob Health. 2015;5(3):231–7. https://doi.org/10.1016/j.jegh.2014.11.002.CrossRefPubMedPubMedCentral

30.

Norman R, Gaziano T, Laubscher R, Steyn K, Bradshaw D. Estimating the burden of disease attributable to high blood pressure in South Africa in 2000. S Afric Med J. 2007;97(8 Pt 2):692–8.

31.

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57. https://doi.org/10.1016/S0140-6736(06)68770-9.CrossRefPubMed

32.

Takashima N, Ohkubo T, Miura K, Okamura T, Murakami Y, Fujiyoshi A, et al. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens. 2012;30(12):2299–306. https://doi.org/10.1097/HJH.0b013e328359a9f7.CrossRefPubMed

33.

Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(4):1024.CrossRefPubMed

34.

Azimi S, Khalili D, Hadaegh F, Mehrabi Y, Yavari P, Azizi F. Direct estimate of population attributable fraction of risk factors for cardiovascular diseases: Tehran glucose and lipid study. Iran J Epidemiol. 2012;7(4):9–18.

35.

Lee H, Yoon SJ, Ahn HS, Moon OR. Estimation of potential health gains from reducing multiple risk factors of stroke in Korea. Public Health. 2007;121(10):774–80. https://doi.org/10.1016/j.puhe.2007.03.002.CrossRefPubMed

Title: Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths
Authors: Ehsan Mazloumi
Jalal Poorolajal
Nizal Sarrafzadegan
Hamid Reza Roohafza
Javad Faradmal
Manoochehr Karami
Publication date: 01-06-2019
Publisher: Springer International Publishing
Keywords: Obesity
Obesity
Hypertension
Overweight
Hypertension
Published in: High Blood Pressure & Cardiovascular Prevention / Issue 3/2019
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI: https://doi.org/10.1007/s40292-019-00319-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths

Abstract

Introduction

Aim

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Aim

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2019

Is the Oral Microbiome Associated with Blood Pressure in Older Women?

Vascular Aging and Disease of the Large Vessels: Role of Inflammation

Morning Surge and Peak Morning Ambulatory Blood Pressure Versus Automated Office Blood Pressure in Predicting Cardiovascular Disease

Commentary to “The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease”

Low Density Lipoprotein (LDL) Cholesterol as a Causal Role for Atherosclerotic Disease: Potential Role of PCSK9 Inhibitors

Prevalence and Risk Factors of Hypertension in the Vietnamese Elderly